Dr. Anuchit Chutaputti

Consultant

42 Years of Experience

Gastroenterologist, Hepatologist

MD, Diploma, Fellowship

English, Thai

Consultation Fee $ 26

Book an Appointment

Dr. Anuchit Chutaputti is a well-known gastroenterologist and hepatologist.
With over 42 years of experience, Dr. Chutaputti brings extensive experience to the field of hepatology and gastroenterology.
His expertise and interests lie in providing treatments for bowel obstruction, liver cirrhosis, portal hypertension, viral hepatitis and liver cancer.
Dr. Chutaputti is known for delivering optimal outcomes for his patients while providing expert care surgeries like Whipple surgery and liver resection surgery.
His educational qualifications include an MD in Medicine from Pramongkutklao Hospital, Mahidol University, in 1982 and a Diploma in Internal Medicine from the Thai Board of Internal Medicine in 1988.
Dr. Chutaputti holds a Diploma in Gastroenterology from the Thai Sub Board of Gastroenterology in 2004 and a Fellowship in Hepatology from Yale University, USA, in 1994.
He also served his internship at Phramongkulklao Hospital in Thailand.
Apart from his clinical practice, Dr. Chutaputti is actively involved in academic research. Some of his notable works include the Journal of Gastroenterology and Hepatology, Hepatology International, and more.

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Thongsawat, S., Piratvisuth, T., Pramoolsinsap, C., Chutaputti, A., Tanwandee, T., & Thongsuk, D. (2014). Resource Utilization and Direct Medical Costs of Chronic Hepatitis C in Thailand: A Heavy but Manageable Economic Burden. Value in Health Regional Issues, 3, 12–18. https://doi.org/10.1016/j.vhri.2013.09.002
Treeprasertsuk, S., Tanwandee, T., Piratvisuth, T., Pramoolsinsap, C., Chutaputti, A., Pornpininworakij, K., Ingsrisawang, L., & Mahachai, V. (2013). Natural history, outcome, and sustainability of treatment response in chronic viral hepatitis B: Thai multicenter study. Asian Biomedicine/Asian Biomedicine (Research, Reviews and News), 7(5), 599–607. https://doi.org/10.5372/1905-7415.0705.218
Ahn, S. H., Kweon, Y. O., Paik, S. W., Sohn, J. H., Lee, K. S., Kim, D. J., Piratvisuth, T., Yuen, M. F., Chutaputti, A., Chao, Y. C., Trylesinski, A., & Avila, C. (2011). Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B. Hepatology International, 6(4), 696–706. https://doi.org/10.1007/s12072-011-9314-7
Omata, M., Kanda, T., Yu, M. L., Yokosuka, O., Lim, S. G., Jafri, W., Tateishi, R., Hamid, S. S., Chuang, W. L., Chutaputti, A., Wei, L., Sollano, J., Sarin, S. K., Kao, J. H., & McCaughan, G. W. (2012). APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatology International, 6(2), 409–435. https://doi.org/10.1007/s12072-012-9342-y